Clinical trials
Recruiting Antiphospholipid Syndrome trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 6 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Peking University Third Hospital | 2 |
| Peking Union Medical College Hospital | 1 |
| Peking University People's Hospital | 1 |
| Ruijin Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Antiphospholipid Syndrome | 14 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 10 |
| Lupus Erythematosus, Systemic | 9 |
| Myositis | 9 |
| Scleroderma, Systemic | 8 |
| Sjogren's Syndrome | 6 |
| Lupus Nephritis | 3 |
| Autoimmune Diseases | 2 |
| Immunoglobulin G4-Related Disease | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.